23.08.2017 • News

Clock Ticking on Linde-Praxair Merger

(c) Stepan Bormotov/Shutterstock
(c) Stepan Bormotov/Shutterstock

The 10-week acceptance period for the proposed $74 billion merger of Germany’s Linde with US rival Praxair began on Aug. 15 and will run through Oct. 24, Linde has announced.

If successful, the deal would create a global leader in the global gases market. With a market value of $75 billion at current exchange rates, $30 billion in annual sales and 88,000 employees, the combined company – which will trade as Linde – would pass the current leader, France’s Air Liquide.

With its own acquisition of Airgas in mid-2016 for $13 billion, Air Liquide knocked the standalone Linde out of first place.

Altogether 75% percent of Linde’s shareholders will have to tender their stock to the new company for the merger to succeed.  Praxair needs only a simple majority vote. 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read